Zymeworks Inc. ( ZYME) - Key Metrics
ZYME Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.06 | -$0.62 | -$0.44 | -$0.44 |
| 2026Q1 | $0.03 | -$0.59 | -$0.61 | -$0.61 |
| 2025Q4 | $0.03 | -$0.55 | -$0.13 | -$0.14 |
| 2025Q3 | $0.36 | -$0.26 | -$0.41 | -$0.42 |
| 2025Q2 | $0.65 | $0.03 | $0.16 | $0.15 |
ZYME Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -10.54 |
| 2026Q1 | 0% | -10.61 |
| 2025Q4 | 0% | -11.97 |
| 2025Q3 | 0% | -16.42 |
| 2025Q2 | 0% | 101.87 |
ZYME
Price: $25.15
52 week price:
Earnings Per Share: -2.07 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Canada
Volume: 105946
Ebitda: -15.5 millionMarket Capitalization: 1.9 billion